Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity

Raul Velez-Montoya1, Carmen Clapp2, Jose Carlos Rivera2, Gerardo Garcia-Aguirre1, Virgilio Morales-Cant&oacute;n1, Jans Fromow-Guerra1, Jose Luis Guerrero-Naranjo1, Hugo Quiroz-Mercado31Retina Department Asociaci&oacute;n para Evitar la Ceguera en M&eacute;xico IAP, M&amp...

Full description

Bibliographic Details
Main Authors:	Raul Velez-Montoya, Carmen Clapp, Jose Carlos Rivera, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-08-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/intraocular-and-systemic-levels-of-vascular-endothelial-growth-factor--a5105

Similar Items

Vascular endothelial growth factor inhibitors for retinopathy of prematurity
by: O.V. Zhukova, et al.
Published: (2020-11-01)

Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy
by: Byung Ju Jung, et al.
Published: (2019-01-01)

Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
by: Anil Gangwe, et al.
Published: (2021-01-01)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
by: Xuting Chen, et al.
Published: (2019-01-01)

Refractive errors in premature infants with retinopathy of prematurity after anti-vascular endothelial growth factor (anti-VEGF) therapy
by: Vujanović Milena S., et al.
Published: (2017-01-01)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
by: Ajay Indur Dudani, et al.
Published: (2019-01-01)

Serum Erythropoietin, Insulin-Like Growth Factor 1 and Vascular Endothelial Growth Factor in Ethiopathogenesis of Retinopathy of Prematurity
by: Özlem Yenice, et al.
Published: (2012-12-01)

Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity
by: Manavi D Sindal, et al.
Published: (2021-01-01)

Commentary: Looking beyond anti-vascular endothelial growth factor – Novel therapeutic targets for retinopathy of prematurity
by: Mohit Dogra, et al.
Published: (2021-01-01)

Diabetic retinopathy and vascular endothelial growth factor
by: Majid Khazaei
Published: (2013-01-01)

Association between assisted reproductive technology and advanced retinopathy of prematurity
by: RV Paul Chan, et al.
Published: (2010-11-01)

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.
by: Laura Pertl, et al.
Published: (2015-01-01)

Intravitreal antivascular endothelial growth factors for retinopathy of prematurity in Ibadan: Method of administration
by: Yewande Olubunmi Babalola, et al.
Published: (2020-01-01)

Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy
by: Selim Kocabora, et al.
Published: (2010-01-01)

Relationship between levels of vascular endothelial growth factor in blood and severity of diabetic retinopathy
by: Jebinth Brayan, et al.
Published: (2021-01-01)

Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity
by: Anand Vinekar
Published: (2021-01-01)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
by: Min Zhao, et al.
Published: (2015-01-01)

Relationship between Serum Vascular Endothelial Growth Factor Levels and Stages of Diabetic Retinopathy and Other Biomarkers
by: Nakhleh E. Abu-Yaghi, et al.
Published: (2020-01-01)

Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)
by: Zijing Li, et al.
Published: (2018-01-01)

Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
by: Hui-Jin Chen, et al.
Published: (2019-01-01)

Genetic susceptibility to advanced retinopathy of prematurity (ROP)
by: Shastry Barkur S
Published: (2010-08-01)

Correlation of vascular endothelial growth factor and microvascular damage in diabetic retinopathy
by: Ji-Quan Wen, et al.
Published: (2015-12-01)

Increased levels of vascular endothelial growth factor in aqueous humor of patients with diabetic retinopathy: Is it the whole truth?
by: K S Santhan Gopal
Published: (2011-01-01)

Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy.
by: Ahmed M Abu El-Asrar, et al.
Published: (2013-01-01)

Vascular Endothelial Growth Factor in the Aqueous Humor of Dogs With and Without Intraocular Disease
by: Sandberg, Christina Ann
Published: (2014)

Up close with the vascular loops in aggressive posterior retinopathy of prematurity
by: Biju Raju, et al.
Published: (2019-01-01)

Speed of Retinal Vascularization in Retinopathy of Prematurity: Risk and Protective Factors
by: Ana Maria Solans Pérez de Larraya, et al.
Published: (2019-01-01)

Recent advances of medicine treatment research in retinopathy of prematurity
by: Ling Zheng, et al.
Published: (2014-03-01)

Recent treatment advances in aggressive posterior retinopathy of prematurity
by: Chun-Liu Tian, et al.
Published: (2020-01-01)

Researches advance on anti-VEGF medication for retinopathy of prematurity
by: Huan-Huan Zhao, et al.
Published: (2013-12-01)

Retinopathy of Prematurity
by: Mukta Sharma, et al.
Published: (2018-01-01)

The association study of gene polymorphism of vascular endothelial growth factor with diabetic retinopathy
by: Dong-Hao Li, et al.
Published: (2013-06-01)

Investigation of correlations between vascular endothelial growth factor and proliferative diabetic retinopathy
by: Hong-Li Zhu
Published: (2014-12-01)

Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
by: Obata S, et al.
Published: (2019-12-01)

Relationship of intrauterine growth retardation and retinopathy of prematurity
by: Duo Peng, et al.
Published: (2018-01-01)

Relationships among Retinal Nonperfusion, Neovascularization, and Vascular Endothelial Growth Factor Levels in Quiescent Proliferative Diabetic Retinopathy
by: Ho Ra, et al.
Published: (2020-05-01)

Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
by: Jianbo He, et al.
Published: (2015-01-01)

Pitfalls of Advanced Retinopathy of Prematurity Presentation: A Content Analysis of Medical Records
by: AlBathi L, et al.
Published: (2021-09-01)

Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure
by: Ashiyana Nariani, et al.
Published: (2016-01-01)

The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China
by: Qing-Yu Meng, et al.
Published: (2019-07-01)